Two kidney outcomes were assessed: a composite outcome for chronic kidney disease progression of a 40% or greater decline in estimated glomerular filtration rate, chronic dialysis, kidney transplantation or death from kidney failure
Lee, S., Boesch, C., Kuk, J
or BMI 27+ with prediabetes or history of heart attack, stroke, or peripheral artery disease
Regular intake, alongside a balanced diet and skincare routine, is essential for sustained results
Mounjaro (tirzepatide) : The SURMOUNT trials demonstrated even greater efficacy, with average weight loss of 22.5% at the highest dose after 72 weeks